Categories: Agenda

Investors Put a Microscope on Pay Problems

Companies including Altria GroupCVS Health and Intel are the latest to have failed say on pay so far this proxy season, as investors zero in on longtime compensation issues that have been magnified by the coronavirus pandemic.

Indeed, investors are carefully scrutinizing how pay, strategy and performance will align to weather the storm. Shareholders may react to perceived failings on issues such as employee health and safety by voting against pay to send a strong message, sources say.

Additionally, traditional pain points for investors, such as one-time awards and lack of pay-for-performance alignment, are driving negative vote campaigns that have led to weak say-on-pay vote results for some companies this year.

admin

Recent Posts

How ESG Metrics Are Taking Over Annual Incentive Plans

Compensation committees at S&P 500 companies are increasingly tying annual bonuses to measures beyond financial…

2 weeks ago

Visual Investigation: Pay Gaps Widen as Workforce Scrutiny Grows

The pay gap between CEOs and their employees has widened over the past half decade,…

1 month ago

In a Bumper Year for CEO Pay, One Chief’s $161 Million Award Swells to $1.3 Billion

Chip maker Broadcom gave Hock Tan, its chief executive, a $161 million stock award, instantly…

2 months ago

Are Companies Really Reincorporating in Nevada?

Elon's Musk's $56 billion pay package's upheaval, a hedge fund sanctioned for failing to preserve…

2 months ago

Are Check Marks ‘Cheap Talk’ in Board Skills Matrices?

Disclosures about directors' skills and expertise are increasingly coming under the microscope as investors ramp…

3 months ago

Boards Looking for ‘Soft Skills’ in New Crop of CEOs

On Jan. 1, several of the nation's biggest companies — including Morgan Stanley, Kraft Heinz,…

4 months ago